Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-31732

Single-particle
3.2 Å
EMD-31732
3D View Gallery
Deposition: 18/08/2021
Map released: 22/06/2022
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-31732
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7v61 summary report (pdf.gz) Map and 7v61 FULL report (pdf.gz)
EMICSS annotations (xml)

ACE2 -Targeting Monoclonal Antibody as Potent and Broad-Spectrum Coronavirus Blocker

EMD-31732

Single-particle
3.2 Å
EMD-31732
3D View Gallery
Deposition: 18/08/2021
Map released: 22/06/2022
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Sample: ACE2-B0AT1 complex
Fitted models: 7v61

Deposition Authors: Yan RH, Zhang YY
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker.
Chen Y, Zhang YN, Yan R, Wang G, Zhang Y, Zhang ZR, Li Y, Ou J, Chu W, Liang Z, Wang Y, Chen YL, Chen G, Wang Q, Zhou Q, Zhang B , Wang C
(2021) Signal Transduct Target Ther , 6 , 315 - 315
PUBMED: 34433803
DOI: doi:10.1038/s41392-021-00740-y
ISSN: 2059-3635